News Archive

New York, NY – July 6, 2016 – Dr. Gregg Stone, CRF’s Co-Director of Medical Research and Education, was quoted in articles from the Associated Press and Wall Street Journal on the FDA approval of a new stent which is designed to completely dissolve within three years. The stent was approved for use in patients with coronary artery disease, a condition which causes about 370,000 deaths each year in the U.S. Dr. Stone was chairman of the clinical trial program which studied the new device.